Content Hub
NEWLY ADDED!
CAR-TCR: Article
CAR T: Fireside Chat
Helen Tayton- Martin, CBO, Adaptimmune
André Choulika, CEO,Cellectis
Michael Koslowski, CMO, GammaDelta Therapeutics
Dolores Schendel, CEO, Medigene
Jacob Plieth, Senior Reporter,Vantage Analysis
Presentations
NEWLY ADDED!
CAR-TCR Presentation
CAR T: Continuation in a Revolution of Cancer Therapeutics
Dr. Joseph McGuirk, Professor of Medicine Schutte Speas Professor of Hematology Oncology. Medical Director, BMT and Cellular Therapeutics. Division Director, Hematologic Malignancies and Cellular Therapeutics
NEWLY ADDED!
CAR-TCR Presentation
Overcoming Treatment
Resistance to T Cell
Therapy
Adrian Bot, M.D., Ph.D.
Vice President, Translational Medicine
NEWLY ADDED!
CAR-TCR Presentation
Navigating Regulatory Requirements for
Early Phase CAR-T Clinical Studies
Elena Spanjaard, Global Head of Regulatory Affairs, Celyad
NEWLY ADDED!
CAR-TCR Presentation
CAR T Cells for Solid Tumours, To Do List
Francesco M. Marincola, Chief Research Officer, Refuge Biotechnologies
NEWLY ADDED!
CAR-TCR Presentation
Identification of Novel Shared Targets for Solid Tumors
Hans-Peter Gerber, Ph.D. SVP & CSO,3T Biosciences
NEWLY ADDED!
CAR-TCR Presentation
Cross-Sector Efforts to Advance Gene & Cell Therapy Manufacturing
Michael Lehmicke, Director, Science & Industry Affairs
NEWLY ADDED!
CAR-TCR Presentation
The Bridge to Curative Cellular Therapies
Paul Rennert, CAR-TCR Summit 2019
NEWLY ADDED!
CAR-TCR Presentation
Next generation, contextual regulation of CAR T function in vivo:
Zhifen Yang, Senior Scientist, Refuge Biotechnologies
Magazines
NEWLY ADDED!
CAR-TCR Magazine - Q1